Yogurt: top launches by corporation

Published By Datamonitor

Yogurt: top flavors in new products

Published By Datamonitor

Yogurt: top flavors in new products

Published By Datamonitor

Yogurt: top flavors in new global product launches

Published By Datamonitor

Xarelto data raise questions at the 2010 American Heart Association Scientific Sessions

Results from the ROCKET-AF trial of Xarelto in stroke prevention in atrial fibrillation have been presented at this year's Scientific Sessions of the American Heart Association. While positive, the data show that Xarelto has by no means outperformed Pradaxa. Clinicians may start to see the two drugs as complementary alternatives, based on their respective performance in various subgroups.

Published By Datamonitor

Wyeth: Big Pharma continues its shopping spree

The current economic environment has paved the way for leading pharmaceutical firms to sweep in and buy up smaller players, highlighted by Wyeth's potential acquisition of Crucell and Merck & Co's strategy to aggressively look for targets in 2009. An increasing number of pharmaceutical majors are likely to use this approach to strengthen their biologic portfolios and access novel pipeline drugs.

Published By Datamonitor

Wrigley: introducing itself to the chocolate market

The purchase of an 80% stake in premium chocolate company A. Korkunov will allow Wrigley, which already operates in Russia, to form effective synergies with the company, through leveraging existing distribution networks, and enable it to capitalize on the growing disposable income of the country's burgeoning middle class. The move will also allow it to branch out into chocolate confectionery.

Published By Datamonitor

World trade: Ecuador not bananas about pact

Published By Datamonitor

World Congress on Osteoporosis highlights changing face of bone health

Datamonitor attended this year's International Osteoporosis Foundation World Congress on Osteoporosis and 10th European Congress on Clinical and Economical Aspects of Osteoporosis and Osteoarthritis, the most important meeting on the osteoporosis calendar. A number of major pharmaceutical firms had a presence at the meeting, indicating the significance of this market.

Published By Datamonitor

World Bank: limit on coal funding is a step in the right direction

By restricting funding for coal power stations to all but the poorest countries, the World Bank is taking a step in the right direction towards a greener world. While this move has faced criticism, reducing extreme poverty has to take preference over low carbon energy. Ultimately, the World Bank has to find a way to help poorer countries use funding to develop cleaner alternatives.

Published By Datamonitor